An NCAA committee has made a formal recommendation to remove cannabis from their banned substances list for college athletes.
In a recent press statement (1), the National Collegiate Athletic Association (NCAA) Committee on Competitive Safeguards and Medical Aspects of Sports (CSMAS) formally announced their recommendation that cannabis should be removed from the organization’s banned substances list for college athletes. The committee also stated (10 that all three of the organization’s governing bodies should “introduce and adopt legislation that would remove cannabinoids from the list of NCAA banned drug classes.”
This recommendation reportedly comes after an extensive study informed by industry and subject matter experts. In December 2022, the NCAA also hosted a Summit on Cannabinoids in College Athletics (2). The consensus opinion formed at that event was that cannabis was not a performance-enhancing drug and that a harm-reduction approach to cannabis would be best implemented at the school level.
The NCAA statement reads (1): “In short, removing cannabinoids from the list of banned substances:
"When making a decision on an important topic like this, we agree that the membership should have an opportunity to vote on the final outcome," said James Houle, committee chair and lead sport psychologist at Ohio State (1). "We are recommending a big shift in the paradigm when it comes to cannabinoids. We want to modernize the strategy with the most up-to-date research to give schools the best opportunity to support the health of student-athletes."
The exact timing of discussion and adoption of possible legislation is a decision that will be made by each of three NCAA divisional governance structures (1).
References
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part II: Accreditation in the Cannabis Industry with Susan Audino
October 17th 2024In Part II of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, discuss the challenges in cannabis testing, the THC cap, and the need for better regulations.